Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
European Journal of Neurology|August 4, 2025
Efgartigimod as a Fast-Acting Add-On Therapy in Antibody-Mediated Autoimmune EncephalitisZhuajin Bi, Wenzhong Kang, Ruihan Liu, et al.Muscle & Nerve|February 11, 2022
Differences in immunophenotypes between myasthenia gravis patients with and without thyroid antibodiesQing Zhang, Zhuajin Bi, Mengge Yang, et al.Journal of Neuroimmunology|April 14, 2021
Tacrolimus as a therapeutic option in patients with acquired neuromyotoniaChenchen Liu, Suqiong Ji, Zhuajin Bi, et al.BMC Neurology|September 11, 2021
Overlapping syndrome mimicking infectious meningoencephalitis in a patient with MOG and GFAP IgGSuqiong Ji, Chenchen Liu, Zhuajin Bi, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 6, 2024
Long-term efficacy and safety of tacrolimus in anti-MuSK antibody-positive myasthenia gravis: a retrospective single-center cohort studyZhuajin Bi, Yue Li, Jing Lin, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 25, 2020
Correlation between anemia and clinical severity in subacute combined degeneration patientsZhuajin Bi, Jie Cao, Ke Shang, et al.Frontiers in Neurology|May 25, 2023
Increased expression of cell adhesion molecules in myofasciitisXue Ma, Huajie Gao, Li Xu, et al.Therapeutic Advances in Neurological Disorders|February 16, 2026
Efgartigimod for Guillain-Barré syndrome: a retrospective analysis of efficacy and safetyZhuajin Bi, Xiaodong Ye, Peidong Liu, et al.Frontiers in Neurology|May 13, 2025
Resolution of anti-GAD-associated autoimmune encephalitis in patients treated with efgartigimodMin Chen, Zhuajin Bi, Wenzhong Kang, et al.Biomed Research International|September 4, 2020
Hypertrophic Pachymeningitis in Chinese Patients: Presentation, Radiological Findings, and Clinical CourseZhuajin Bi, Ke Shang, Jie Cao, et al.Pageof 3